Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignancies, Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07234110
What this trial is testing

CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors

Who this might be right for
Relapsed and Refractory CD5 Hematological Tumors
Institute of Hematology & Blood Diseases Hospital, China 18
Not applicableStudy completedNCT04826523
What this trial is testing

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 150
Testing effectiveness (Phase 2)UnknownNCT04935580
What this trial is testing

Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 20
Early research (Phase 1)Study completedNCT00058396
What this trial is testing

Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Not applicableNot Yet RecruitingNCT06785870
What this trial is testing

EVAluation of Erythrocytosis PRospEctive Cohort STudy

Who this might be right for
ErythrocytosisPolycythemiaPolycythemia Secondary+5 more
Cyrus Hsia 1,500
Testing effectiveness (Phase 2)Ended earlyNCT02078960
What this trial is testing

Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 10
Large-scale testing (Phase 3)Study completedNCT00005596
What this trial is testing

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 1,076
Post-approval studies (Phase 4)Looking for participantsNCT06876662
What this trial is testing

(LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Eli Lilly and Company 279
Early research (Phase 1)Looking for participantsNCT06088888
What this trial is testing

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Shenzhen TargetRx Co., Ltd. 90
Not applicableStudy completedNCT03720561
What this trial is testing

Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen-Cilag S.p.A. 312
Not applicableStudy completedNCT05275543
What this trial is testing

Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab

Who this might be right for
Pediatric ALLChild, HospitalizedPhysical Therapy Modalities+2 more
University of Nebraska 25
Not applicableLooking for participantsNCT06743035
What this trial is testing

Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

Who this might be right for
Polycythemia Vera
iOMEDICO AG 200
Testing effectiveness (Phase 2)Study completedNCT00002674
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 30
Not applicableEnded earlyNCT00897910
What this trial is testing

Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 6
Not applicableStudy completedNCT03433560
What this trial is testing

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

Who this might be right for
Breast Cancer FemaleBreast Neoplasm Female
Kyowa Kirin Korea Co., Ltd. 1,300
Testing effectiveness (Phase 2)UnknownNCT03598179
What this trial is testing

XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects

Who this might be right for
Lymphoma, B-CellLeukemia, B-cell
The First Affiliated Hospital with Nanjing Medical University 10
Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Very early researchUnknownNCT03228303
What this trial is testing

Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Assiut University 100
Not applicableActive Not RecruitingNCT05208086
What this trial is testing

Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 180
Next Page